IL3 and Sepsis: The isolated use of this cytokine was not superior to otherbiomarkers and clinical scores classically used as predictors of outcome in sepsis.The benefit of using IL-3 as an isolated marker or as part of a biomarker panel forprognostic characterization and risk stratification in sepsis patients must beevaluated in future investigations.